SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005125
Filing Date
2016-05-02
Accepted
2016-05-02 17:10:13
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20160331x10q.htm 10-Q 1175632
2 EX-31.1 xncr-20160331ex3112999bc.htm EX-31.1 19514
3 EX-31.2 xncr-20160331ex3122bc1a7.htm EX-31.2 19524
4 EX-32.1 xncr-20160331ex3218577a4.htm EX-32.1 10240
  Complete submission text file 0001558370-16-005125.txt   4590046

Data Files

Seq Description Document Type Size
5 EX-101.INS xncr-20160331.xml EX-101.INS 1003499
6 EX-101.SCH xncr-20160331.xsd EX-101.SCH 29070
7 EX-101.CAL xncr-20160331_cal.xml EX-101.CAL 38322
8 EX-101.DEF xncr-20160331_def.xml EX-101.DEF 99850
9 EX-101.LAB xncr-20160331_lab.xml EX-101.LAB 319293
10 EX-101.PRE xncr-20160331_pre.xml EX-101.PRE 215453
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 161612547
SIC: 2834 Pharmaceutical Preparations